Daré Bioscience Provides Business Update and Announces Third Quarter Financial Results
13 nov. 2018 07h30 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today provided a business update and announced financial...
Daré to Host Third Quarter 2018 Financial Results Conference Call and Webcast
06 nov. 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that it will host a conference call and live...
Daré Announces Two Late-Breaking Abstracts to be Presented at the American Association of Pharmaceutical Scientists (AAPS) in Washington D.C.
30 oct. 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that it will be presenting two late-breaking...
Daré Bioscience, Inc. to Present at the Dawson James Small Cap Growth Conference
23 oct. 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will...
Daré Bioscience, Inc. to Present an Overview of Novel Intra-Vaginal Ring (IVR) Technologies at the Partnership Opportunities in Drug Delivery (PODD) Meeting Held in Boston, MA October 17th – 18th
15 oct. 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s health-focused biopharmaceutical company, today announced it will be presenting...
Daré Bioscience, Inc. to Present at the 2018 BIO Investor Forum
10 oct. 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that Sabrina Martucci Johnson, President and...
Greg Matz Joins Daré Bioscience Board of Directors
17 sept. 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of Greg Matz to its board of...
Daré Bioscience, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference
30 août 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will...
Daré Bioscience, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
02 août 2018 08h00 HE
|
Dare Bioscience, Inc.
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will...
Daré Bioscience, Inc. Announces Asset Transfer Agreement with Hydra Biosciences, Inc. for CatSper Contraceptive Target
16 juil. 2018 08h00 HE
|
Dare Bioscience, Inc.
CatSper antagonist has potential to provide pregnancy prevention via administration to either women or men as a novel, rapidly reversible, non-hormonal contraceptive SAN DIEGO, July 16, 2018 ...